Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Janssen
Marketing
Judge levies $1.64B penalty on J&J in HIV drug marketing case
Nearly a year after a jury decided that Johnson & Johnson should be fined just over $150 million, a judge has upped the penalty more than tenfold.
Andrea Park
Mar 31, 2025 10:39am
J&J sues Samsung Bioepis over Stelara biosimilar agreement
Feb 25, 2025 10:21am
Janssen, Roche lead reputation rankings in common cancers
Jun 21, 2024 10:59am
J&J plugs €580M into Italy operations
Jun 20, 2024 9:12am
J&J to appeal guilty verdict in $150M HIV false claims case
Jun 17, 2024 12:07pm
100 not out: J&J celebrates UK centenary with new name and look
May 1, 2024 3:00am
